Tuesday, November 25, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

B Riley Securities Analyst Reiterates Neutral Rating on LB Foster with Increased Price Target

Elaine Mendonca by Elaine Mendonca
March 6, 2024
in Breaking News
0
Finance_Budgeting (1)
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

On March 6, 2024, B. Riley Securities analyst Alex Rygiel reiterated a Neutral rating on L.B. Foster (NASDAQ:FSTR) while increasing the price target from $17 to $23. Rygiel’s updated outlook underscores his belief in the company’s growth prospects and market positioning.

FSTR Stock Price Drops 7.96% on March 6, 2024: Will the Trend Continue?

On March 6, 2024, FSTR stock experienced a significant decrease in price, closing at $22.33, which was a drop of $1.93 or 7.96% from the previous market close. This decline in price was also reflected in after-hours trading, with the stock dropping an additional $0.33.

Despite this drop in price, FSTR is still trading near the top of its 52-week range and is currently above its 200-day simple moving average. This indicates that the stock has been performing well over a longer period of time, despite the recent price decrease.

Investors may be keeping a close eye on FSTR to see if the stock will rebound from this drop or if the downward trend will continue. It is important for investors to conduct thorough research and analysis before making any decisions regarding buying or selling FSTR stock.

FSTR Stock Performance Analysis: Revenue Increases, Net Income Mixed

On March 6, 2024, FSTR stock showed mixed performances based on the financial data provided by CNN Money. The total revenue for the company was reported at $543.74 million for the past year, showing an increase of 9.3% compared to the previous year. However, the total revenue for the fourth quarter was $134.88 million, indicating a decrease of 7.2% compared to the previous quarter.

In terms of net income, FSTR reported a net income of $1.46 million for the past year, which represented a significant increase of 103.21% compared to the previous year. However, the net income for the fourth quarter was -$430.00 thousand, indicating a slight decrease compared to the previous quarter.

Earnings per share (EPS) for FSTR were reported at $0.13 for the past year, showing an increase of 103.13% compared to the previous year. The EPS for the fourth quarter was -$0.04, which remained unchanged compared to the previous quarter.

Overall, the financial performance of FSTR on March 6, 2024, showed a mixed picture. While there were significant improvements in net income and earnings per share compared to the previous year, the company experienced a decrease in total revenue and a slight decrease in net income compared to the previous quarter. Investors and analysts may need to further analyze the company’s financial health and future prospects before making investment decisions regarding FSTR stock.

Tags: FSTR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands

Analyst Reaffirms Sell Rating on Stellus Capital Investment with Lower Price Target

Biotechnology Stock Market Today (1)

Harvard Bioscience Inc Unveils CuttingEdge Product Advancements for Research at SOT Conference

The Rise of Strategic Partnerships in Life Sciences: Trends Shaping the Future of Healthcare Innovation

BTIG Analyst Gray Powell Optimistic about HashiCorps Future Growth

Recommended

Pfizer Stock

Pfizer’s Billion-Dollar Acquisition Fails to Impress Investors

1 week ago
DIS stock news

Mastercard: A Leader in Financial Innovation and Stability for Investors

2 years ago
Par Pacific Stock

Par Pacific’s Q3 2025 Earnings: A Critical Juncture for the High-Flying Stock

3 weeks ago
Intuitive Surgical Stock

Intuitive Surgical: A Tale of Strong Operations and Weak Investor Sentiment

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials NIO Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Voestalpine Shares Surge on Major Analyst Upgrade

CureVac’s Final Chapter: A Surprise Profit Paves Way for BioNTech Takeover

Ethereum Gains Momentum as Institutional Investors Return

PacWest Shares Continue Their Steep Decline Amid Sector Concerns

Vulcan Energy Shares Find Their Footing After Recent Setbacks

Micron’s Unprecedented Demand Signals Major Upside for Shares

Trending

Bitcoin Stock
Bitcoin

Bitcoin’s Critical Juncture: Recovery Rally or Bear Trap?

by Felix Baarz
November 25, 2025
0

As November 2025 concludes, Bitcoin investors face one of the most challenging monthly performances in recent history....

AngioDynamics Stock

AngioDynamics Shares Surge on Strong Fundamentals and Regulatory Momentum

November 25, 2025
Diamondback Stock

Diamondback Energy: A Battle of Titans Amid Market Contradictions

November 25, 2025
Voestalpine Stock

Voestalpine Shares Surge on Major Analyst Upgrade

November 25, 2025
CureVac Stock

CureVac’s Final Chapter: A Surprise Profit Paves Way for BioNTech Takeover

November 25, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Bitcoin’s Critical Juncture: Recovery Rally or Bear Trap?
  • AngioDynamics Shares Surge on Strong Fundamentals and Regulatory Momentum
  • Diamondback Energy: A Battle of Titans Amid Market Contradictions

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com